17089-462 NDC - GUNA LYMPHO DETOX (AESCULUS HIPPOCASTANUM - APIS MELLIFERA - CALENDULA OFFICINALIS FLOWER - HEXAKETOCYCLOHEXANE - EQUISETUM HYEMALE - FUMARIC ACID - GRAPHITE - HYDRASTIS CANADENSIS - HYDROCOTYLE ASIATICA - JUGLANS REGIA - LEVOTHYROXINE - MAGNESIUM PHOSPHATE - MALIC ACID - MYOSOTIS ARVENSIS - PHYTOLACCA AMERICANA ROOT - SARSAPARILLA - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUS SCROFA PLACENTA - TARAXACUM OFFICINALE -)

Drug Information

  • Product NDC: 17089-462
  • Proprietary Name: GUNA LYMPHO DETOX
  • Non Proprietary Name: Aesculus hippocastanum - apis mellifera - calendula officinalis flower - hexaketocyclohexane - equisetum hyemale - fumaric acid - graphite - hydrastis canadensis - hydrocotyle asiatica - juglans regia - levothyroxine - magnesium phosphate - malic acid - myosotis arvensis - phytolacca americana root - sarsaparilla - sodium diethyl oxalacetate - sodium pyruvate - sus scrofa placenta - taraxacum officinale -
  • Active Ingredient(s): 8 [hp_X]/30mL APIS MELLIFERA; 1 [hp_X]/30mL CALENDULA OFFICINALIS FLOWER; 2 [hp_X]/30mL CENTELLA ASIATICA WHOLE; 6 [hp_X]/30mL DODECAHYDROXYCYCLOHEXANE DIHYDRATE; 3 [hp_X]/30mL EQUISETUM HYEMALE; 6 [hp_X]/30mL FUMARIC ACID; 5 [hp_X]/30mL GOLDENSEAL; 12 [hp_X]/30mL GRAPHITE; 2 [hp_X]/30mL HORSE CHESTNUT; 5 [hp_X]/30mL JUGLANS REGIA FRUIT RIND, IMMATURE; 12 [hp_X]/30mL LEVOTHYROXINE; 12 [hp_X]/30mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; 6 [hp_X]/30mL MALIC ACID; 4 [hp_X]/30mL MYOSOTIS ARVENSIS; 4 [hp_X]/30mL PHYTOLACCA AMERICANA ROOT; 3 [hp_X]/30mL SARSAPARILLA; 6 [hp_X]/30mL SODIUM DIETHYL OXALACETATE; 6 [hp_X]/30mL SODIUM PYRUVATE; 6 [hp_X]/30mL SUS SCROFA PLACENTA; 1 [hp_X]/30mL TARAXACUM OFFICINALE
  • Administration Route(s): ORAL
  • Dosage Form(s): SOLUTION/ DROPS
  • Pharmacy Class(es): Allergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Standardized Insect Venom Allergenic Extract [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Thyroxine [CS]; l-Thyroxine [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Guna spa
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:9/24/2020

Package Information

No. Package Code Package Description Billing Unit
117089-462-181 BOTTLE, DROPPER in 1 BOX (17089-462-18) / 30 mL in 1 BOTTLE, DROPPER

NDC Record

Field Name Field Value Definition
PRODUCT NDC17089-462The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEGUNA LYMPHO DETOXThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAesculus hippocastanum - apis mellifera - calendula officinalis flower - hexaketocyclohexane - equisetum hyemale - fumaric acid - graphite - hydrastis canadensis - hydrocotyle asiatica - juglans regia - levothyroxine - magnesium phosphate - malic acid - myosotis arvensis - phytolacca americana root - sarsaparilla - sodium diethyl oxalacetate - sodium pyruvate - sus scrofa placenta - taraxacum officinale -The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/24/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGuna spaName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAPIS MELLIFERA; CALENDULA OFFICINALIS FLOWER; CENTELLA ASIATICA WHOLE; DODECAHYDROXYCYCLOHEXANE DIHYDRATE; EQUISETUM HYEMALE; FUMARIC ACID; GOLDENSEAL; GRAPHITE; HORSE CHESTNUT; JUGLANS REGIA FRUIT RIND, IMMATURE; LEVOTHYROXINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MALIC ACID; MYOSOTIS ARVENSIS; PHYTOLACCA AMERICANA ROOT; SARSAPARILLA; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUS SCROFA PLACENTA; TARAXACUM OFFICINALEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH8; 1; 2; 6; 3; 6; 5; 12; 2; 5; 12; 12; 6; 4; 4; 3; 6; 6; 6; 1 
ACTIVE INGRED UNIT[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL 
PHARM CLASSESAllergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Thyroxine [CS], l-Thyroxine [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 7/4/2025

Previous Code
Next Code